Rational Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Rational Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$456K	Buy	+54,000	New	+$455K	0.04%	356

Other funds holding PDLI

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Rational Advisors's PDLI Position: Q4 2013 in Review

Rational Advisors opened a new position in PDL BioPharma, Inc. (PDLI) in Q4 2013: 54,000 shares worth $456K. The stake represents 0.04% of the portfolio and ranks #356 among its holdings.

224 funds tracked by Wall St. Rank hold PDLI as of Q4 2013.

Rational Advisors held 54,000 shares of PDL BioPharma, Inc. worth $456K as of Q4 2013.
PDL BioPharma, Inc. was a new Rational Advisors position in Q4 2013.
PDL BioPharma, Inc. made up 0.04% of Rational Advisors's portfolio in Q4 2013, its #356 holding.
224 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2013.

Based on Rational Advisors's 13F filing for Q4 2013, filed 17 Feb 2015.